CellSource Co

CellSource Co Enterprise Value

The Enterprise Value (EV) of CellSource Co (4880.T) as of Oct 27, 2026 is 3.12 B JPY. In the previous year, Enterprise Value (EV) was 3.53 B JPY — a change of -11.66% (lower).

Enterprise Value

3.12 BJPY

YoY

-11.66%

Last updated:

Enterprise Value (EV) of CellSource Co is 2025 3.12 B JPY. Enterprise Value (EV) of CellSource Co was 2024 3.53 B JPY. It decreases by -11.66% lower compared to the previous year.

The CellSource Co Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
7.52 B JPY
Jan 1, 2019
6.45 B JPY
Jan 1, 2020
6.02 B JPY
Jan 1, 2021
5.36 B JPY
Jan 1, 2022
4.65 B JPY
Jan 1, 2023
3.09 B JPY
Jan 1, 2024
3.53 B JPY
Jan 1, 2025
3.12 B JPY
The CellSource Co Enterprise Value history
YEAREnterprise ValueYoY
3.12 BJPY-11.66%
3.53 BJPY+14.24%
3.09 BJPY-33.56%
4.65 BJPY-13.34%
5.36 BJPY-10.89%
6.02 BJPY-6.62%
6.45 BJPY-14.27%
7.52 BJPY-1.61%
7.64 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Enterprise Value (EV) of CellSource Co is 3.12 B JPY in 2025.

Enterprise Value (EV) of CellSource Co changed from 3.53 B JPY to 3.12 B JPY, representing a -11.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) CellSource Co since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s JPY, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' JPY varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s CellSource Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — CellSource Co

All Key Metrics — CellSource Co